BioLineRx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.

CEO

Philip Adam Serlin

CEOPhilip Adam Serlin

Employees

Employees38

Headquarters

Modi'in, HaMerkaz

HeadquartersModi'in, HaMerkaz

Founded

2003

Founded2003

Employees

Employees38

BLRX Key Statistics

Market cap

52.23M

Market cap52.23M

Price-Earnings ratio

-0.67

Price-Earnings ratio-0.67

Dividend yield

—

Dividend yield—

Average volume

234.76K

Average volume234.76K

High today

$0.68

High today$0.68

Low today

$0.6109

Low today$0.6109

Open price

$0.655

Open price$0.655

Volume

307.57K

Volume307.57K

52 Week high

$2.53

52 Week high$2.53

52 Week low

$0.5528

52 Week low$0.5528

BLRX News

TipRanks 1d

BioLineRx receives Nasdaq minimum bid price notification - TipRanks.com - TipRanks

BioLineRx announced that it has received a notification letter from the Nasdaq Stock Market LLC. The letter notifies the company that it is not in compliance wi...

TipRanks 2d

BioLineRx Faces Nasdaq Compliance Challenge - TipRanks.com - TipRanks

Bioline RX Ltd Sponsored ADR (BLRX) has released an update. BioLineRx Ltd., an Israel-based biopharmaceutical company, has been notified by Nasdaq of non-compl...

Yahoo Finance 2d

BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification - Yahoo Finance

TEL AVIV, Israel, May 17, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a commercial stage biopharmaceutical c...